期刊文献+

舒肝健骨方对成骨样细胞增殖分化的影响及雌激素活性的检测 被引量:5

Effects of Shugan Jiangu Decoction on Osteoblast-Like Cells Proliferation,Differentiation and Evaluation of Estrogenic Potential of Decoction
原文传递
导出
摘要 目的:观察舒肝健骨方对成骨样细胞增殖分化的影响,并检测舒肝健骨方是否有雌激素活性。方法:培养成骨样细胞MG-63,给予不同浓度的舒肝健骨方处理后,MTT法检测复方对MG-63细胞增殖的影响;对硝基苯酚法检测复方对MG-63细胞碱性磷酸酶(Alkaline phosphatase,ALP)活性的影响。培养MCF-7细胞,转染萤火虫荧光素酶和海肾荧光素酶质粒,双荧光素酶报告基因检测试剂检测复方雌激素活性。结果:舒肝健骨方在处理MG-63细胞48,72 h时,0.75~12 g·L-1的剂量能促进成骨样细胞增殖,并且呈现剂量依赖性;在作用24,48,72 h时,促进成骨样细胞碱性磷酸酶活性,呈剂量依赖性。舒肝健骨方的雌激素活性与阴性对照相比无统计学差异,与阳性对照雌二醇相比有显著性差异(P<0.05)。结论:舒肝健骨方能够促进成骨样细胞的增殖分化,并且无雌激素活性。 Objective: To investigate the effects of Shugan Jiangu decoction on osteoblast-like cells and evaluate the estrogenic potential of the decoction.Method: Human osteoblast-like cells MG-63 were cultured and treated with Shugan Jiangu decoction.Cell proliferation was investigated by MTT assay.Alkaline phosphatase activity,as indicator of cell differentiation,was assayed by p-nitrophenylphosphate(pNPP) method.After transient cotransfection with plasmid pERE-TK-Luc and pRL-TK in MCF-7 cells,we evaluated the estrogenic potential of Shugan Jiangu decoction by dual-luciferase reporter assay(DLR).Result: By MTT assay,at 48,72 h,Shugan Jiangu decoction(0.75-12 g·L^-1) increased osteoblast-like cell proliferation dose-dependently.By pNPP method assay,at 24,48,72 h,the decoction enhanced alkaline phosphatase activity dose-dependently.By DLR assay,there was no significant difference in estrogenic potential between Shugan Jiangu decoction and negative control.Conclusion: Shugan Jiangu decoction stimulated osteoblast-like cells proliferation and differentiation.No estrogenic potential was observed for Shugan Jiangu decoction.
作者 任艳 李萍萍
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第13期141-144,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 北京市中医局科技项目(2004京中重IV15)
关键词 舒肝健骨方 成骨样细胞MG-63 碱性磷酸酶 雌激素活性 Shugan Jiangu decoction osteoblast-like cells MG-63 alkaline phosphatase activity estrogenic potential
  • 相关文献

参考文献10

  • 1Eisen A,Trudeau M,Shelley W,et al.Aromatase inhihitors in adjuvant therapy for hormone receptor positive breast cancer:A systematic review[J].Cancer Treatment Reviews,2008,34(2):157.
  • 2Janni W,Hepp P.Adjuvant aromatase inhibitor therapy:outcomes and safety[J].Cancer treatment reviews,2010,36(3):249.
  • 3Zhang Y,Li P P.Shu-Gan-Liang-Xue Decoction,a Chinese herbal formula,down-regulates the expression of steroid sulfatase genes in human breast carcinoma MCF-7cells[J].J Ethnopharmacology,2010,127(3):620.
  • 4Zhang Y,Li P P.Evaluation of estrogenic potential of Shu-Gan-Liang-Xue Decoction by dual-lnciferase reporter based bioluminescent measurements in vitro[J].J Ethnopharmacology,2009,126(2):345.
  • 5朱慧锋,王唯佳,王珠美.骨碎补研究进展[J].中国骨伤,2009,22(1):66-68. 被引量:38
  • 6闫兴丽,张建军,曾凤英.三种牡蛎矿质元素的含量测定与分析[J].中国中医基础医学杂志,2009,15(3):218-218. 被引量:8
  • 7Coelho M J,Fernandes M H.Human bone cell cultures in hiocompatibility testing.Part Ⅱ:effect of ascorbic acid,beta-glycerophosphate and dexamethasone on osteoblastic differentiation[J].Biomaterials,2000,21(11):1095.
  • 8Medicines and Healthcare Products Regulatory Agency and Committee on Safety of Medicines.Review of the evidence on long-term safety of HRT[J].Pharmacovigilance,2004,30:4.
  • 9Herman Adlercreutz.Phytoestrogens and breast cancer[J].The Journal of Steroid Biochemistry and Molecular Biology,2002,83(1/5):113.
  • 10Bord S,Ireland D C,Beavan S R,et al.The effects of estrogen on osteoprotegerin,RANKL,and estrogen receptor expression in human osteoblasts[J].Bone,2003,32(2):136.

二级参考文献26

共引文献44

同被引文献51

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部